相关实验视频

Updated: Jan 8, 2026

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

可编程大型货物集成:克服下一代基因治疗的尺寸限制

Lifang Yu¹, Mario Andrea Marchisio²

¹School of Chemistry and Chemical Engineering, Huangshan University, Huangshan, 245041, PR China.

Synthetic and systems biotechnology

|December 24, 2025

概括

新的基因组编辑工具,如基因和主要编辑器,可以实现精确的DNA修改. 本综述强调了三种先进的系统,用于高效地插入大型DNA片段 (>1kb),以克服目前基因治疗的局限性.

科学领域:

分子生物学分子生物学
遗传学是一个遗传学.
生物技术是生物技术.

背景情况:

基础和主要编辑器提供精确的基因组编辑,没有双链断裂 (DSB).
这些工具有助于精确的点突变,插入,删除和替换.
目前的局限性存在于有效地插入大型DNA片段 (>1kb) 来纠正复杂的遗传突变.

研究的目的:

对高效的大型DNA货物插入 (>1kb) 的新策略进行审查.
检查这些系统在细菌和哺乳动物环境中的应用,优势和局限性.
确定大规模DNA插入技术的持续挑战和未来研究方向.

主要方法:

对三种最近开发的大型DNA插入策略的审查:与CRISPR相关的TN7类转化酶 (CAST),PE整合酶系统和R2逆转化素融合 (nCas9-R2).
在细菌和哺乳动物系统中分析系统应用.
讨论每个系统的比较优势和当前局限性.

主要成果:

CAST,PE-整合酶系统和nCas9-R2融合表明了高效的大型DNA载荷插入 (>1kb) 的潜力.
这些系统在细菌和哺乳动物细胞环境中都显示出适用性.
每个系统都具有独特的优势和局限性,涉及到效率,特异性和货物的尺寸.

结论:

先进的基因组编辑系统正在出现,以实现高效的大型DNA片段插入.
这些技术有望通过克服当前的局限性来推进基因疗法和个性化基因组医学.
需要进一步的研究来解决持续的挑战,并优化这些系统用于更广泛的临床应用.

关键词:

这里是CAST和CAST.临床治疗临床治疗大量的DNA插入.在PE-整合酶中,在 nCas9-R2 中.

更多相关视频

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

Cloning and Large-Scale Production of High-Capacity Adenoviral Vectors Based on the Human Adenovirus Type 5

Cloning and Large-Scale Production of High-Capacity Adenoviral Vectors Based on the Human Adenovirus Type 5

Published on: January 28, 2016

相关概念视频

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.